FIBROGEN INC·4

Oct 19, 8:41 PM ET

Rosenkranz Roberto Pedro 4

4 · FIBROGEN INC · Filed Oct 19, 2018

Insider Transaction Report

Form 4
Period: 2018-10-18
Transactions
  • Sale

    Common Stock

    2018-10-18$53.88/sh64$3,44933,636 total
  • Exercise/Conversion

    Common Stock

    2018-10-18$9.78/sh+1,000$9,77533,700 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2018-10-181,0002,000 total
    Exercise: $9.78Exp: 2023-04-17Common Stock (1,000 underlying)
  • Sale

    Common Stock

    2018-10-18$55.49/sh936$51,93932,700 total
Footnotes (3)
  • [F1]Shares sold pursuant to a 10b5-1 Plan.
  • [F2]The shares were sold at prices ranging from $55.30 and $55.55. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F3]Fully vested.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION